Q6A917 AF NFT

Aspartate carbamoyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifbpngid3cwkvpzjb4w2mffp6njjan6mbnvvszati75gep3ux66ri/metadata.json
IPFS of structure file: 
bafybeibozlvakuqt2eazyawct3xaxudfvoiya6cmrnfywyum6dvzzyigvy/AF-Q6A917-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xc747B9121c6447a3B7701F18EEF77222C7A174F2
First NFT owner address (bech32): 
genesis1carmjysuv3r68dmsruvwaamjytr6za8j6ynh5e
Current NFT ID #325016 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
325016
Accession (UniProt):
Q6A917
Name::
Aspartate carbamoyltransferase
Experimental Method:
Predicted structure
Sequence source:
Cutibacterium acnes (strain DSM 16379 / KPA171202)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6A917 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6A917|PYRB_CUTAK Aspartate carbamoyltransferase OS=Cutibacterium acnes (strain DSM 16379 / KPA171202) OX=267747 GN=pyrB PE=3 SV=1 MSTEVVEEFDADYTGRHFLSVEDMSSDDVMRIIERGRQFKAGDAPRVEPGHVAINMFFENSTRTMTSFQMAEHRLGMKILDFDPGHSSVTKGESLYDSVRTVDAIGAEVAVIRHSTNHYYDYLLATGMLGLSVVNGGDGSGQHPSQCMLDLMTIAEEFGHVDGLTVAISGDIVHSRVARSDAQILTRLGANVVFTGPREWMDHDVTRLGTMATLDEVIADVDVAMMLRVQHERFDAGPDFSATDYLHTFGLTDERAERMKPHAIIMHPAPVNRGCEISGHLVEAPSSRIFEQMGNGVMVRMAILEQVLHGRETK